Use of polymorphism analysis requires ethical guidelinesBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7258.453/a (Published 12 August 2000) Cite this as: BMJ 2000;321:453
- Martin A Myers, consultant clinical biochemist (Martin.Myers@patr.nhs.uk)
- Clinical Biochemistry Department, Royal Preston Hospital, Preston PR2 4HG
EDITOR—In their review on pharmacogenetics Wolf et al state that one day it may be considered unethical not to carry out pharmacogenetic testing routinely.1 I agree, but the ethical use of such testing must be clearly defined.
Because of advances in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial